HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 335 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,598 | +5.9% | 68 | 0.0% | 0.00% | – |
| Q2 2023 | $2,453 | -15.5% | 68 | -10.5% | 0.00% | -100.0% |
| Q1 2023 | $2,902 | -32.9% | 76 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $4,324 | +44.1% | 76 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $3,000 | 0.0% | 76 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $3,000 | 0.0% | 76 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $3,000 | 0.0% | 76 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $3,000 | +200.0% | 76 | +192.3% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 26 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 26 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | -50.0% | 26 | -43.5% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 46 | +100.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 23 | +27.8% | 0.00% | – |
| Q1 2020 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |